Zero Childhood Cancer Clinical Trial delivers promising results within it’s first 11 months

1 year ago  •  By  •  0 Comments

As a founding funder of 'Zero Childhood Cancer', CTx is very pleased to see that the initial results of its national clinical trial, released today, reveal promising outcomes within its first 11 months

Of the 129 children enrolled in the trial from across Australia with high-risk and relapsed cancers, 67% were provided with personalised treatment plans aimed at killing their unique cancer cells. For most children enrolled in the trial, there were otherwise few to no treatment options available to them.

Led by Children’s Cancer Institute and the Kids’ Cancer Centre at Sydney Children’s Hospital, Randwick, Zero Childhood Cancer is one of the world’s most comprehensive child cancer personalised medicine studies. The trial uses sophisticated genetic tests to scientifically analyse each child’s individual cancer cells to identify and recommend new personalised treatment options.

Read the full story here